The Week in Diabetes and Endocrinology April 17, 2026
The Week in Diabetes & Endocrinology — Episode 003 | April 17, 2026
From Hormone Insight (hormoneinsight.com)
Six stories th...
Hormone Insight
Share:
Listens: 302
About
Discuss Diabetes and Endocrinology studies in a simplified manner. Expand your knowledge in Diabetes and Endocrinology.
Episode 002: LDL Under 55 Wins Big, Medicare Covers GLP-1, and Second Weekly Insulin Emerges -- The Week in Diabetes & Endocrinology (April 10, 2026)
The Week in Diabetes & Endocrinology — Episode 002 | April 10, 2026
From Hormone Insight (hormoneinsight.com)
Six stories ...
From Hormone Insight (hormoneinsight.com)
Six stories ...
The Week in Diabetes and Endocrinology -- April 3, 2026
The Week in Diabetes & Endocrinology — Episode 001 | April 3, 2026
From Hormone Insight (hormoneinsight.com)
Six stories thi...
Early Onset Type 2 Diabetes and Tirzepatide (SURPASS Post Hoc Analysis)
In this episode of Hormone Insight, we examine a 2024 post hoc analysis published in Diabetes Care.
Exploring Semaglutide: Therapy for Obesity and Heart Failure
Exploring Semaglutide: Dual Action Therapy for Obesity and Heart Failure
Semaglutide vs Canagliflozin for Type 2 Diabetes
In this episode of Hormone Insight, we delve into a major study published in The Lancet Diabetes and Endocrin...
Study Shows Tirzepatide Improves Heart Failure Outcomes and Quality of Life in Obese Patients
In patients with heart failure with preserved ejection fraction (HFpEF) and obesity, tirzepatide significantly reduced the composi...
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes
In patients with type 2 diabetes, intensive blood-pressure control (targeting systolic BP <120 mm Hg) significantly reduce...
Phase 2 trial on Semaglutide
This episode explores the potential of semaglutide, a once-weekly GLP-1...